EcoR1 Capital LLC 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 1:36 pm Sale |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 0 0.000% |
-2,759,505![]() (Position Closed) |
Filing |
2022-02-14 3:03 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 2,759,505 5.900% |
655,555![]() (+31.16%) |
Filing |
2021-02-16 12:10 pm Purchase |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 2,103,950 5.600% |
2,103,950![]() (New Position) |
Filing |